VTGN

$0.17+0.30%visit website

Vistagen Therapeutics, Inc.

Market Cap

$7M

Live price × SEC shares (Aug 10, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.63

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

3.0

TTM to Jun 2026 · revenue

P/B

0.3

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q2 FY2026 Sep 30, 2025	Q3 FY2026 Dec 31, 2025	Q4 FY2026 Mar 31, 2026	Q1 FY2027 Jun 30, 2026	TTM Jun 30, 2026
Revenue	258	303	465	1,476	2,502
Research & development	15,915	14,223	13,060	10,906	54,104
Total operating expenses	20,311	19,849	17,182	14,824	72,166
Operating income	(20,053)	(19,546)	(16,717)	(13,348)	(69,664)
Pretax income	(19,417)	(18,899)	(16,267)	(13,030)	(67,613)
Income tax	0.00	0.00	7.00	0.00	7.00
Net income	(19,417)	(18,899)	(16,274)	(13,030)	(67,620)
EPS (basic) ($)	(0.54)	(0.45)		(0.30)	(1.66)
EPS (diluted) ($)	(0.54)	(0.45)		(0.30)	(1.66)
Weighted avg. shares (basic)	35,749	42,234		42,980
Weighted avg. shares (diluted)	35,749	42,234		42,980

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

25 filings in 12 months · 3 with priority itemsFull history →

Filed	Items	Filing
Oct 30, 2026 accepted 5:24 PM ET	2.05Restructuring costs8.01Other events	Document SEC ↗
Oct 9, 2026 accepted 5:15 PM ET	5.02Officer / director change	Document SEC ↗
Sep 25, 2026 accepted 9:11 AM ET	7.01Reg FD disclosure	Document SEC ↗
Sep 24, 2026 accepted 7:05 AM ET	8.01Other events	Document SEC ↗
Sep 22, 2026 accepted 4:22 PM ET	8.01Other events	Document SEC ↗
Sep 11, 2026 accepted 7:24 PM ET	5.07Shareholder vote	Document SEC ↗
Aug 14, 2026 accepted 8:40 AM ET	2.02Earnings release	Document SEC ↗
Aug 6, 2026 accepted 4:16 PM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Aug 5, 2026 accepted 4:04 PM ET	3.01Delisting notice	Document SEC ↗
Jul 31, 2026 accepted 8:48 AM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗